Genzyme Corp. Chief Executive Officer Henri Termeer will receive $158.4 million in the sale of his Cambridge, Massachusetts-based biotechnology company to French drugmaker Sanofi-Aventis SA, according to a regulatory filing.
BusinessWeek.com -- Top News, Business Week
Mon, 03/07/2011 - 8:12am
Genzyme Corp. Chief Executive Officer Henri Termeer will receive $158.4 million in the sale of his Cambridge, Massachusetts-based biotechnology company to French drugmaker Sanofi-Aventis SA, according to a regulatory filing.